Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation
Yun Xiao, Guilin Qiao, Juan Tang, et al.
The Journal of Immunology (2015) Vol. 195, Iss. 9, pp. 4218-4227
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Exhaustion-associated regulatory regions in CD8 + tumor-infiltrating T cells
Giuliana P. Mognol, Roberto Spreafico, Victor Wong, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 13
Open Access | Times Cited: 279
Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer
James Clarke, Bharat Panwar, Ariel Madrigal, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 9, pp. 2128-2149
Open Access | Times Cited: 221
TCR Signal Strength and T Cell Development
Nicholas R. J. Gascoigne, Vasily Rybakin, Oreste Acuto, et al.
Annual Review of Cell and Developmental Biology (2016) Vol. 32, Iss. 1, pp. 327-348
Open Access | Times Cited: 153
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia
Juan Tang, Sha Tu, Guoxin Lin, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 4
Open Access | Times Cited: 137
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 816-837
Closed Access | Times Cited: 9
K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity
Qiuming Zeng, Hui Guo, Na Tang, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Regulation of immune responses by E3 ubiquitin ligase Cbl-b
Rong Tang, Wallace Y. Langdon, Jian Zhang
Cellular Immunology (2018) Vol. 340, pp. 103878-103878
Open Access | Times Cited: 72
JAK–STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis
Raphaël Clère-Jehl, Alexandre Mariotte, Ferhat Meziani, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 11, pp. 987-1002
Open Access | Times Cited: 56
Turning the Tide Against Regulatory T Cells
SeongJun Han, Aras Toker, Zhe Qi Liu, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 55
Specific CD8+T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
E. Moreno-Cubero, J.R. Larrubia
World Journal of Gastroenterology (2016) Vol. 22, Iss. 28, pp. 6469-6469
Open Access | Times Cited: 53
Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy
Shubhangi Gavali, Jianing Liu, Xinyi Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10800-10800
Open Access | Times Cited: 37
Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Cbl-b Deficiency Mediates Resistance to Programed Death-Ligand 1/Programed Death-1 Regulation
Mai Fujiwara, Emily J. Anstadt, Robert B. Clark
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 35
Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity
Poojitha Sitaram, Bradley Uyemura, Subramaniam Malarkannan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5821-5821
Open Access | Times Cited: 30
T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells
Emily Mercadante, Ulrike Lorenz
The Journal of Immunology (2017) Vol. 199, Iss. 1, pp. 129-137
Open Access | Times Cited: 33
TAM receptors attenuate murine NK‐cell responses via E3 ubiquitin ligase Cbl‐b
Leilani M. Chirino, Suresh Kumar, Mariko Okumura, et al.
European Journal of Immunology (2019) Vol. 50, Iss. 1, pp. 48-55
Open Access | Times Cited: 29
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 14-31
Open Access | Times Cited: 24
Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells
Song Ouyang, Qiuming Zeng, Na Tang, et al.
The Journal of Immunology (2019) Vol. 202, Iss. 5, pp. 1441-1452
Open Access | Times Cited: 25
Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways
Yadhu Sharma, Altaf Ahmad, Samina Bashir, et al.
Future Oncology (2016) Vol. 12, Iss. 10, pp. 1287-1298
Closed Access | Times Cited: 22
Quantitative Interactomics of Lck-TurboID in Living Human T Cells Unveils T Cell Receptor Stimulation-Induced Proximal Lck Interactors
Xien Yu Chua, Timothy J. Aballo, William ElNemer, et al.
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 715-726
Open Access | Times Cited: 19
Application of ATAC-seq in tumor-specific T cell exhaustion
Chufeng Chen, Jiaying Liu, Yidong Chen, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 1-10
Open Access | Times Cited: 12
Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition
Sebastian Peer, Gottfried Baier, Thomas Gruber
Oncotarget (2017) Vol. 8, Iss. 26, pp. 41841-41853
Open Access | Times Cited: 20
TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1–Mediated Inactivation of LCK
João V. S. Ormonde, Zhigang Li, Camille Stegen, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 11, pp. 3431-3442
Open Access | Times Cited: 20
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
Giulia Monticone, Zhi Huang, Fred Csibi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation
Charles W. Tran, Samuel D. Saibil, Thierry Le Bihan, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 12, pp. 4056-4065
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top